![]() ![]() Building the evidence base for the positive outcomes that arise from acting upon laboratory diagnostic information is actually a difficult task. And yet, this sector of healthcare informs the majority of health care management, estimated at “up to 70% of decisions.” 1, 2 To date, very few laboratories or pathologists are actively engaged in providing leadership for optimizing integration of laboratory diagnostics into clinical workflows and population management. In vitro diagnostics, the healthcare industry term for clinical laboratory services, represents US$73 billion of the US$3 trillion spend on US healthcare-about 2.5%. In so doing, our aim is to empower regional and local laboratories to thrive under new models of payment in the next era of American health care delivery. In the very simplest sense, this effort to create “Clinical Lab 2.0” will establish the impact of laboratory diagnostics on the full 100% spend in American healthcare, not just the 2.5% spend attributed to in vitro diagnostics. ![]() We also hope that, through such activities, the evidence base will be created for the new value propositions of integrated laboratory networks. In so doing, clinical laboratories can be effectors in identifying patients at risk for escalation in care, closing gaps in care, and optimizing outcomes of health care innovation. This call to action is more than working with industry stakeholders on the basis of our expertise it is providing leadership in creating the programs that accomplish these objectives. Specifically, in the transition from volume-based to value-based health care, clinical laboratories are called upon to provide programmatic leadership in reducing total cost of care through optimization of time-to-diagnosis and time-to-effective therapeutics, optimization of care coordination, and programmatic support of wellness care, screening, and monitoring. We provide recommendations from the inaugural March 2016 meeting of Project Santa Fe. The participants in Project Santa Fe represent major regional health systems that can operationalize laboratory-driven innovations and test their valuation in diverse regional marketplaces in the United States. Straub's laboratories are accredited by the College of American Pathologists and have federal Clinical Laboratory Improvement Act (CLIA) certification.Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. ![]() In addition, Straub's pathologists provide evaluation of surgical biopsies, cytology smears and autopsy slides. Under the direction of board-certified pathologists, laboratory staff provide chemistry, hematology, urinalysis, serology, coagulation, microbiology, blood-banking, serology, cytology and histology services. The satellite clinic labs at Pearlridge, Hawaii Kai, Kailua, Kaneohe, Mililani and King Street provide basic lab services. Straub's clinical laboratories provide a full range of services for both inpatients and outpatients at its King Street location. We do all this so that we can trust that our tests are accurate and reliable. We partner with accredited laboratories that specialize in certain testing and which are staffed with highly skilled doctors, scientists and technicians. Laboratory & Pathology Laboratory & Pathologyĭoctors rely on lab tests to provide key information that they use to decide patients’ diagnoses and treatments. ![]()
0 Comments
Leave a Reply. |